Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 26, 2006 Brian Gorman	Delta and Pine's Cotton-Pickin' Challenge Delta and Pine disclosed this week that it has purchased Syngenta's global cotton seed business. India promises to be a huge market, but there's more work ahead.
The Motley Fool August 15, 2006 Stephen D. Simpson	Second Time the Charm? Eight years after an ill-fated initial merger attempt, Monsanto is once again trying to buy cottonseed specialist Delta and Pine Land in an all-cash $1.5 billion proposed merger. Investors, take note.
The Motley Fool July 6, 2006 Stephen D. Simpson	Delta and Pine Land Grows on Investors A strong quarter sends the stock of the seed company to a 52-week high.
The Motley Fool April 6, 2005 W.D. Crotty	Fast-Blooming Biotech Monsanto's net sales and net income soar in the second quarter. Is it time to buy this stock?
The Motley Fool January 6, 2006 Stephen D. Simpson	Investors Don't Cotton to Delta Cotton-seed producers Delta and Pine Land's first quarter is usually sleepy, but investors still found reasons to sell.
The Motley Fool April 4, 2006 Stephen D. Simpson	The Look and Feel of Delta & Pine's Cotton Delayed shipments hurt this quarter, but increased acreage estimates are good news for the cottonseed specialist. Investors: buy, sell or hold?
The Motley Fool January 3, 2007 Emil Lee	Delta & Pine Land Continues The Dance with Monsanto Can this couple get together? Given the uncertainty surrounding the merger, arbitrageurs may wish to dabble in Delta's stock.
The Motley Fool January 4, 2007 Brian Gorman	Monsanto's Bigger Harvest? High corn prices could allow Monsanto to raise seed prices and improve margins. Investors, take note.
The Motley Fool February 18, 2005 Brian Gorman	Monsanto Cottons to Emergent Monsanto's second acquisition in less than a month signals an aggressive move into cotton seeds. Investors will no doubt keep a close eye on this one.
The Motley Fool April 3, 2006 Rich Smith	Foolish Forecast: Delta & Pine Land When considering this farming company's margin trends, it's best for investors to focus on rolling gross and operating margins and be leery of drawing conclusions from the net results.
The Motley Fool October 10, 2007 Billy Fisher	Monsanto's Monster Year There's no doubt that 2007 has been a monster year for Monsanto, due to the craze over ethanol and corn, but will it last looking forward?
The Motley Fool June 26, 2008 Brian Orelli	Why Throw Tomatoes at Monsanto? There wasn't a lot to complain about in Monsanto's third-quarter earnings report, but investors found enough disappointing news to send the stock down.
The Motley Fool January 6, 2010 Brian Orelli	Monsanto Needs to Round Up Some Growth Monsanto announces a $0.03 first-quarter loss compared with $1.00 per share of income a year ago. That's not exactly starting the year off on the right foot.
The Motley Fool July 30, 2004 Brian Gorman	In China, Hope for Modified Seeds China leans toward allowing genetically modified crops, a potential windfall for Monsanto and competitors.
The Motley Fool January 25, 2005 Brian Gorman	Monsanto Picks Seminis Monsanto's latest acquisition provides a sensible avenue for growth. Investors apparently are less than thrilled about the deal, because they sent the stock down almost 7% in trading.
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
The Motley Fool March 2, 2005 Brian Gorman	Monsanto's Brazil Benefit Brazil is on the cusp of legalizing genetically modified seed sales, a potential boon for Monsanto.
The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.
The Motley Fool January 2, 2007 Rich Duprey	Foolish Forecast: Monsanto Blooms What will crop up in the agricultural behemoth's first-quarter 2007 earnings?
BusinessWeek January 21, 2010 Jack Kaskey	Monsanto Will Let Bio-Crop Patents Expire Genetically engineered soybeans will go generic, but woe to anyone that crosses the seed giant on new products.
The Motley Fool April 5, 2006 Stephen D. Simpson	This GM Actually Works Monsanto's path may be strewn with weeds, but rewards could still lurk within. This is a good company, and looks to be undervalued by a mid-teens percentage. Investors, take note.
The Motley Fool July 17, 2007 Brian Orelli	A Fruitful Collaboration Monsanto and BASF team up to grow better plants. Long-term investors should take it as a sign that Monsanto and BASF are putting their capital to good use.
The Motley Fool September 11, 2009 Brian Orelli	Monsanto Plowed Down Is it bad news, or a bad-news buy?
The Motley Fool August 2, 2007 Brian Orelli	Monsanto Counts Beans Agricultural giant Monsanto is one step closer to launching its new soybean. In field-testing the new seeds have demonstrated a 7%-11% increase in yield.
The Motley Fool April 13, 2006 Brian Gorman	Monsanto's New Challenge The ag-biotech firm faces new competitive pressures from rivals and an ongoing wariness of GM crops in Europe.
The Motley Fool June 29, 2010 Brian Orelli	Foolish Forecast: Monsanto 2.0 With Monsanto's herbicide Roundup facing cheap generic competition, the agriculture giant has planted its hopes for growth solely in the field of biotech seeds.
The Motley Fool June 29, 2011 Brian Orelli	Monsanto Is Back From the Dead Roundup makes a triumphant return, but investors should focus on the seed business.
The Motley Fool April 4, 2006 Rich Smith	Foolish Forecast: Monsanto Still Growing Although the winter quarter isn't usually strong for agriculture, Monsanto's rolling numbers support its CEO's assessment of the business. Over the past 18 months, the company has managed to grow its gross margins 60 basis points. Investors, take note.
Registered Rep. April 1, 2006 Bob Hirschfeld	Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly?
The Motley Fool June 24, 2009 Brian Orelli	The Death of a Cash Cow The company knew a drop in Roundup sales was coming with the patent expiring, but Monsanto has a backup plan.
The Motley Fool May 19, 2004 Brian Gorman	U.N. Plants Seed for Agribusiness Its endorsement of biotech foods could clear the way for agribusiness in the developing world.
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool October 8, 2009 Toby Shute	Monsanto's Solid Year in Seeds The agriculture giant closes the books on a fine year and looks forward.
The Motley Fool September 17, 2010 Dave Mock	3 Reasons to Sell Monsanto Today Monsanto faces serious competitive threats on several fronts, threats that could continue to pressure the stock.
The Motley Fool June 28, 2006 Brian Gorman	Monsanto's Stealth Buys Several small acquisitions should keep profits buoyant as demand for corn rises. Investors, take note.
BusinessWeek April 29, 2010 Kaskey & Ligi	The Seed Makers Who Don't Pray for Rain Agricultural companies tweak crops to flourish with less.
The Motley Fool June 29, 2005 Stephen D. Simpson	Feast or Famine at Monsanto Disappointing guidance will hurt the agribusiness company's stock, but the business still seems quite good.
The Motley Fool July 21, 2009 Brian Orelli	Monsanto and Dow Create Super Corn Sometimes you need a little help from a friend.
The Motley Fool January 19, 2010 Brian Orelli	Monsanto's Legal Wins Are Just the Beginning The lawyers may affect the stock price for a while.
The Motley Fool September 16, 2008 Brian Orelli	Monsanto's Guidance Keeps Growing Monsanto announces another change in financial guidance, which fortunately continued the upward trend.
The Motley Fool October 15, 2010 Tim Hanson	Monsanto's Pain Is Syngenta's Gain Monsanto may be down, but Syngenta and others in the sector are on the upswing.
Chemistry World September 8, 2015 Matthew Gunther	Syngenta to sell off seed business after failed Monsanto takeover The current plan to divest their seed division is intended to 'accelerate shareholder value creation', according to Syngenta's chairman Michel Demare.
The Motley Fool December 15, 2009 Brian Orelli	Why Does Everyone Hate Monsanto? Sometimes the mean guy wins.
The Motley Fool May 27, 2008 Brian Orelli	Super Seed Swap Instead of continuing to fight each other in court, agribusiness companies Syngenta and Monsanto called a truce for their never-ending patent disputes last week.
The Motley Fool August 20, 2009 Brian Orelli	Monsanto Fights Back Monsanto and DuPont have escalated their squabble over DuPont's license of Monsanto's Roundup Ready gene.
The Motley Fool December 7, 2009 Jordan DiPietro	How Terrible Is Monsanto? Monsanto, the global provider of agricultural products, finds its reputation being slammed in a recent food documentary, Food Inc. Which is Monsanto -- savior or sinner?
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool October 13, 2005 Brian Gorman	Monsanto's Abundant Harvest The agricultural technology giant's strong 2005 results demonstrate that business is on track. As for the future, the company now expects fiscal 2006 earnings to be between $2.35 and $2.50 per share, up from a June prediction of $2.34.
The Motley Fool March 26, 2008 Brian Orelli	Monsanto's Guidance Grows Like a Weed The company has had good reasons to set its sights higher. Can Monsanto's current upbeat news keep going strong?
The Motley Fool January 8, 2009 Brian Orelli	Monsanto's Back! Monsanto blew the doors off Wall Street's estimates, and raised yearly guidance by 5% at the low end.